<DOC>
	<DOCNO>NCT01191424</DOCNO>
	<brief_summary>The purpose study demonstrate CHF 1535 ( fix combination Beclometasone Dipropionate ( BDP ) 100 µg / Formoterol Fumarate ( FF ) 6 µg ) deliver via NEXT Dry Powder Inhaler ( DPI ) show great exposure BDP , Beclometasone-17-Monopropionate ( B17MP , active metabolite BDP ) FF comparison free combination BDP DPI plus FF DPI license product morning dose administration BDP FF ( total dose BDP 400 µg / FF 24 µg ) adolescent adult asthmatic patient .</brief_summary>
	<brief_title>A Study Comparing Pharmacokinetic , Pharmacodynamic Safety CHF 1535 ( Fixed Combination Beclomethasone + Formoterol ) Administered Via NEXT DPI , Versus Free Combination Licenced Beclomethasone DPI Formoterol DPI Asthmatic Adolescent Adult Patients .</brief_title>
	<detailed_description />
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Main 1 . Male female adolescent ( ≥ 12 year old ) adult ( ≥18 ≤ 65 year old ) 2 . Written informed consent ; 3 . Diagnosis asthma define GINA guideline ; 4 . Patients stable asthma , accord Investigator 's opinion ; 5 . Asthmatic patient already treat ICS use shortacting inhaled β2agonists reliever control asthma symptom ; 6 . Patients force expiratory volume one second ( FEV1 ) &gt; 70 % predicted value ; 7 . Patients peak inspiratory flow ( PIF ) &gt; 40 L/min 8 . Reversibility test ; 9 . Non exsmokers ; 10 . A cooperative attitude ability train proper use DPI compliant study procedure ; Main 1 . Pregnant lactate female ; 2 . Having receive investigational drug within 2 month screen visit 3 . Diagnosis COPD define current GOLD guideline ; 4 . Significant medical history and/or treatment cardiac , renal , neurological , hepatic , endocrine disease , laboratory abnormality ; 5 . Known hypersensitivity active treatment ; 6 . History drug addiction excessive use alcohol ; 7 . Treatment xanthine derivative ( e.g . theophylline ) formulation 4 week prior screen ; 8 . Hospitalization due asthma exacerbation asthma exacerbation within 1 month prior screen visit ; 9 . Inability perform require breathing technique blood sampling ; 10 . Lower respiratory tract infection within 1 month prior screen visit ; 11 . Blood donation ( 450 mL ) significant blood loss 12 week screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>PK</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Adults</keyword>
</DOC>